Cellular interactions between activated microglia and degenerating neurons in in vivo models of Parkinson’s disease are not well defined. This time course study assesses the dynamics of morphological and immunophenotypic properties of activated microglia in a 6‐hydroxydopamine (6‐OHDA) model of Parkinson’s disease. Neurodegeneration in the substantia nigra pars compacta (SNc) was induced by unilateral injection of 6‐OHDA into the medial forebrain bundle. Activated microglia, identified using monoclonal antibodies: clone of antibody that detects major histocompatibility complex (MHC) class II antigens (OX6) for MHC class II, clone of antibody that detects cell surface antigen‐cluster of differentiation 11b – anti‐complement receptor 3, a marker for complement receptor 3 and CD 68 for phagocytic activity. Activation of microglia in the lesioned SNc was rapid with cells possessing amoeboid or ramified morphology appeared on day 1, whilst antibody clone that detects macrophage‐myeloid associated antigen immunoreactivity was observed at day 3 post‐lesion when there was no apparent loss of tyrosine hydroxylase (TH)+ve dopaminergic (DA) SNc neurons. Thereafter, OX6 and antibody clone that detects macrophage‐myeloid associated antigen activated microglia selectively adhered to degenerating axons, dendrites and apoptotic (caspase 3+ve) DA neurons in the SNc were observed at day 7. This was followed by progressive loss of TH+ve SNc neurons, with the peak of TH+ve cell loss (51%) being observed at day 9. This study suggests that activation of microglia precedes DA neuronal cell loss and neurons undergoing degeneration may be phagocytosed prematurely by phagocytic microglia.
A method for capturing gait signatures in neurological conditions that allows comparison of human gait with animal models would be of great value in translational research. However, the velocity dependence of gait parameters and differences between quadruped and biped gait have made this comparison challenging. Here we present an approach that accounts for changes in velocity during walking and allows for translation across species. In mice, we represented spatial and temporal gait parameters as a function of velocity and established regression models that reproducibly capture the signatures of these relationships during walking. In experimental parkinsonism models, regression curves representing these relationships shifted from baseline, implicating changes in gait signatures, but with marked differences between models. Gait parameters in healthy human subjects followed similar strict velocity dependent relationships which were altered in Parkinson's patients in ways that resemble some but not all mouse models. This novel approach is suitable to quantify qualitative walking abnormalities related to CNS circuit dysfunction across species, identify appropriate animal models, and it provides important translational opportunities.Walking is a complex behavior that requires not only control of initiation and termination of locomotion, but also ongoing adjustments of speed, stride length, cadence, direction, and posture in response to dynamic internal and external cues. Walking can be affected in many different ways secondary to musculoskeletal or cardiovascular problems, as well as dysfunction of the peripheral or the central nervous system (CNS). Gait disorders due to specific CNS circuit pathologies can be clinically recognized based upon phenomenology, such as shuffling gait or festination in Parkinson's disease or ataxic gait in cerebellar disorders 1, 2 . The wide variety of causal conditions and subtypes of gait disorders illustrate that abnormal function or pathology in multiple CNS networks differentially affect gait.Human gait can be objectively measured using direct or indirect kinematic, spatial or temporal measures via video-analysis, footfall studies, or wearable devices. Advances in imaging technology have allowed visualization of putative supratentorial circuitries involved in gait control [3][4][5][6][7][8][9] . However, the functional-anatomical basis for the various gait abnormalities so readily recognized in clinical settings remains poorly understood as approaches to isolate relevant networks during life are relatively limited. This gap in knowledge stands in the way of the development of specific, circuit based treatment strategies targeted to the various specific gait abnormalities.Animal models offer a means to circumvent current barriers of studying gait in humans. In mice, highly selective approaches are now available to identify components of CNS circuits from cortex to spinal cord that mediate or modulate locomotion, including walking 10-13 . Effects of interventions can then be measured u...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.